Allison Wey | VP, IR and Corporate Communications |
Joseph Hagan | President and CEO |
Timothy M. Wright | Chief Research and Development Officer |
Dan Chevallard | CFO |
Liana Moussatos | Wedbush Securities |
Alan Carr | Needham & Company |
Eric Schmidt | Cowen and Company |
Jennifer | B. Riley FBR |
Good day, ladies and gentlemen, and welcome to the Regulus Therapeutics First Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. Later we'll conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Ms.